Healthcare - Biotechnology - NASDAQ - US
$ 3.03
-19.8 %
$ 148 M
Market Cap
-1.59
P/E
Price Target
Average
568.32%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
41.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cabaletta Bio, Inc.
Wall Street analysts predict an average 1-year price target for CABA of $20.2 , with forecasts ranging from a low of $3 to a high of $32 .
CABA Lowest Price Target
Wall Street Target
3 USD
-0.99%
CABA Average Price Target
Wall Street Target
20.2 USD
568.32%
CABA Highest Price Target
Wall Street Target
32 USD
956.11%
REVENUE FORECAST
Revenue Forecast Chart CABA
EBIT FORECAST
EBIT Forecast Chart CABA
NET INCOME FORECAST
Net Income Chart CABA